Cargando…
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study
BACKGROUND: The optimal timing of initiating or resuming anticoagulation after acute ischemic stroke (AIS) or transient ischemic attack (TIA) in patients with atrial fibrillation (AF) is debated. Dabigatran, a non-vitamin K oral anticoagulant (NOAC), has shown superiority against vitamin K antagonis...
Autores principales: | Grosse, Gerrit M, Hüsing, Anika, Stang, Andreas, Kuklik, Nils, Brinkmann, Marcus, Nabavi, Darius, Sparenberg, Paul, Weissenborn, Karin, Gröschel, Klaus, Royl, Georg, Poli, Sven, Michalski, Dominik, Eschenfelder, Christoph C, Weimar, Christian, Diener, Hans-Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676026/ https://www.ncbi.nlm.nih.gov/pubmed/37306492 http://dx.doi.org/10.1177/17474930231184366 |
Ejemplares similares
-
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study
por: Grosse, Gerrit M., et al.
Publicado: (2021) -
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists – the RIC-ICH study
por: Kuklik, Nils, et al.
Publicado: (2023) -
Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran
por: Held, Valentin, et al.
Publicado: (2016) -
Predictive value of the Essen Stroke Risk Score and Ankle Brachial Index in acute ischaemic stroke patients from 85 German stroke units
por: Weimar, C, et al.
Publicado: (2008) -
Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010)